Brief: Lineage Cell Therapeutics Raises $35.9 Million From Sales Of Marketable Securities Holdings And An At-The-Market Equity Offering
March 8 (Reuters) - Lineage Cell Therapeutics Inc LCTX.A :
* LINEAGE CELL THERAPEUTICS RAISES $35.9 MILLION FROM SALES
OF
MARKETABLE SECURITIES HOLDINGS AND AN AT-THE-MARKET EQUITY
OFFERING
* LINEAGE CELL THERAPEUTICS INC - IMPROVED CASH POSITION
EXPECTED
TO FUND OPERATIONS FOR MORE THAN TWO YEARS
Source text for Eikon: ID:nBw3LQBVra
Further company coverage: LCTX.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lineage Cell Therapeutics
See all newsLineage Cell Therapeutics Q2 revenue falls but posts profit
Brief: Lineage Cell Therapeutics Q2 Income From Operations USD -8.923 Million
Lineage Cell Therapeutics Q1 net loss widens as expenses rise
Lineage Cell Q4 revenue rises on Genentech collaboration
Brief: Lineage Cell Therapeutics FY Income From Operations USD -36.619 Million